Virtual Press Office and PR Newswire: General Trade show news https://tradeshownews.vporoom.com/ Oracle's Dr. Sanjay Basu Confirmed to Speak at TCW LIVE! Panel on the Future of AI Infrastructure https://tradeshownews.vporoom.com/2026-06-16-Oracles-Dr-Sanjay-Basu-Confirmed-to-Speak-at-TCW-LIVE-Panel-on-the-Future-of-AI-Infrastructure Tue, 16 Jun 2026 12:19:00 -0400 https://tradeshownews.vporoom.com/2026-06-16-Oracles-Dr-Sanjay-Basu-Confirmed-to-Speak-at-TCW-LIVE-Panel-on-the-Future-of-AI-Infrastructure VITURE Unveils Helix, the First AI Safety Glasses Built on NVIDIA's XR AI Solution, at AWE 2026 https://tradeshownews.vporoom.com/2026-06-16-VITURE-Unveils-Helix,-the-First-AI-Safety-Glasses-Built-on-NVIDIAs-XR-AI-Solution,-at-AWE-2026 Tue, 16 Jun 2026 12:00:00 -0400 https://tradeshownews.vporoom.com/2026-06-16-VITURE-Unveils-Helix,-the-First-AI-Safety-Glasses-Built-on-NVIDIAs-XR-AI-Solution,-at-AWE-2026 Taiwan Excellence Opens Dialogue on AI Mobility Deployment at ITSACE 2026 https://tradeshownews.vporoom.com/2026-06-16-Taiwan-Excellence-Opens-Dialogue-on-AI-Mobility-Deployment-at-ITSACE-2026 Tue, 16 Jun 2026 10:48:00 -0400 https://tradeshownews.vporoom.com/2026-06-16-Taiwan-Excellence-Opens-Dialogue-on-AI-Mobility-Deployment-at-ITSACE-2026 Clinical Trials on Alzheimer's Disease Conference and Alzheimer's Drug Discovery Foundation Partner to Advance Emerging Biotech Innovation at CTAD 2026 https://tradeshownews.vporoom.com/2026-06-16-Clinical-Trials-on-Alzheimers-Disease-Conference-and-Alzheimers-Drug-Discovery-Foundation-Partner-to-Advance-Emerging-Biotech-Innovation-at-CTAD-2026 Tue, 16 Jun 2026 09:30:00 -0400 https://tradeshownews.vporoom.com/2026-06-16-Clinical-Trials-on-Alzheimers-Disease-Conference-and-Alzheimers-Drug-Discovery-Foundation-Partner-to-Advance-Emerging-Biotech-Innovation-at-CTAD-2026 Akston's AKS-699 Demonstrates Pruritus Control Sustained Through One Year, Comparable to lokivetmab with Fewer Treatments, in Head-to-Head Canine IL-31 Challenge Study https://tradeshownews.vporoom.com/2026-06-16-Akstons-AKS-699-Demonstrates-Pruritus-Control-Sustained-Through-One-Year,-Comparable-to-lokivetmab-with-Fewer-Treatments,-in-Head-to-Head-Canine-IL-31-Challenge-Study Tue, 16 Jun 2026 09:30:00 -0400 https://tradeshownews.vporoom.com/2026-06-16-Akstons-AKS-699-Demonstrates-Pruritus-Control-Sustained-Through-One-Year,-Comparable-to-lokivetmab-with-Fewer-Treatments,-in-Head-to-Head-Canine-IL-31-Challenge-Study